These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32313136)

  • 21. Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy.
    Chai RJ; Werner H; Li PY; Lee YL; Nyein KT; Solovei I; Luu TDA; Sharma B; Navasankari R; Maric M; Sim LYE; Loh YJ; Aliwarga E; Cheong JWL; Chojnowski A; Autio MI; Haiyang Y; Boon Tan KK; Keng CT; Ng SL; Chew WL; Ferenczi M; Burke B; Foo RSY; Stewart CL
    Nat Commun; 2021 Aug; 12(1):4722. PubMed ID: 34354059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated MTORC1 signaling and impaired autophagy.
    Ramos FJ; Kaeberlein M; Kennedy BK
    Autophagy; 2013 Jan; 9(1):108-9. PubMed ID: 23064282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.
    Widyastuti HP; Norden-Krichmar TM; Grosberg A; Zaragoza MV
    BMC Med Genet; 2020 Jul; 21(1):152. PubMed ID: 32698886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation.
    Chatzifrangkeskou M; Yadin D; Marais T; Chardonnet S; Cohen-Tannoudji M; Mougenot N; Schmitt A; Crasto S; Di Pasquale E; Macquart C; Tanguy Y; Jebeniani I; Pucéat M; Morales Rodriguez B; Goldmann WH; Dal Ferro M; Biferi MG; Knaus P; Bonne G; Worman HJ; Muchir A
    Hum Mol Genet; 2018 Sep; 27(17):3060-3078. PubMed ID: 29878125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene.
    Rodriguez BM; Khouzami L; Decostre V; Varnous S; Pekovic-Vaughan V; Hutchison CJ; Pecker F; Bonne G; Muchir A
    Hum Mol Genet; 2018 Oct; 27(19):3353-3360. PubMed ID: 29982513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse.
    Cupesi M; Yoshioka J; Gannon J; Kudinova A; Stewart CL; Lammerding J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1290-7. PubMed ID: 19913544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
    Zhang X; Shao X; Zhang R; Zhu R; Feng R
    Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of desmin network defects by αB-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation.
    Galata Z; Kloukina I; Kostavasili I; Varela A; Davos CH; Makridakis M; Bonne G; Capetanaki Y
    J Mol Cell Cardiol; 2018 Dec; 125():73-86. PubMed ID: 30342008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
    Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
    Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.
    Lee YK; Jiang Y; Ran XR; Lau YM; Ng KM; Lai WH; Siu CW; Tse HF
    Stem Cell Res Ther; 2016 Sep; 7(1):139. PubMed ID: 27649756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
    Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
    J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
    Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.
    Jia Y; Chang HC; Schipma MJ; Liu J; Shete V; Liu N; Sato T; Thorp EB; Barger PM; Zhu YJ; Viswakarma N; Kanwar YS; Ardehali H; Thimmapaya B; Reddy JK
    PLoS One; 2016; 11(8):e0160755. PubMed ID: 27548259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
    Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
    Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
    Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
    J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
    Cowan J; Li D; Gonzalez-Quintana J; Morales A; Hershberger RE
    Circ Cardiovasc Genet; 2010 Feb; 3(1):6-14. PubMed ID: 20160190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival.
    Choi JC; Wu W; Phillips E; Plevin R; Sera F; Homma S; Worman HJ
    Hum Mol Genet; 2018 Jul; 27(13):2290-2305. PubMed ID: 29668927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.